AI Transforms Drug Discovery And Development
In December, The Conversation hosted a webinar where Eric Smalley interviewed Jeffrey Skolnick (Georgia Tech) and Benjamin P. Brown (Vanderbilt) about AI’s accelerating role in biomedical research and drug discovery, focusing on protein‑structure prediction, molecular design, and disease‑trajectory analysis. They highlighted advances such as AlphaFold’s structure predictions and AI’s integration of petabytes of data to suggest repurposing and broad‑spectrum treatment hypotheses, while stressing experimental validation.
Scoring Rationale
Interview with credible experts offers industry‑wide relevance and practical implications; novelty is moderate since it summarizes existing advances (AlphaFold, data integration) and lacks deep technical detail, but strong credibility and timeliness raise the score.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read OriginalAI is reengineering drug discovery by speeding up testing and scanning petabytes of data for connections between diseasestheconversation.com
